The quality of life in Ecuadorian patients with multiple sclerosis and neuromyelitis optica spectrum disorder and their association with anxiety, depression, fatigue, and disability - Report - MDSpire
Advertisement
The quality of life in Ecuadorian patients with multiple sclerosis and neuromyelitis optica spectrum disorder and their association with anxiety, depression, fatigue, and disability
Quality of Life Among Ecuadorian Individuals with MS and NMOSD
Overview
This study evaluates the quality of life (QoL) in Ecuadorian patients with multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD), highlighting significant differences in QoL, anxiety, depression, and fatigue between the two conditions. NMOSD patients exhibited a more compromised QoL and higher disability scores compared to MS patients.
Background
Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) are chronic autoimmune conditions that significantly impact patients' quality of life (QoL). Understanding the factors influencing QoL in these populations is crucial for improving patient care and management strategies. This study addresses a gap in research regarding QoL in NMOSD patients, particularly in the context of Latin America.
Data Highlights
Condition
QoL Score
EDSS Score
Anxiety Level
Depression Level
Fatigue
MS
Lower QoL
Lower EDSS
Mild
Mild
More frequent
NMOSD
More compromised QoL
Higher EDSS
Moderate/Severe
Mild
Less frequent
Key Findings
QoL was significantly more compromised in NMOSD patients compared to MS patients (p < 0.005).
NMOSD patients had elevated EDSS scores compared to MS patients (p < 0.05).
Anxiety and depression were prevalent in both conditions, with NMOSD patients experiencing more severe anxiety.
Fatigue was observed more frequently in MS patients than in NMOSD patients (p < 0.01).
Younger NMOSD patients had lower QoL scores.
Correlations were found between disability, fatigue, anxiety, and depression with QoL in both MS and NMOSD patients.
Clinical Implications
Healthcare providers should be aware of the significant impact of anxiety, depression, and fatigue on the quality of life in patients with MS and NMOSD. Early identification and management of these psychological factors may improve patient outcomes and overall QoL. Tailored interventions addressing these issues are essential in clinical practice.
Conclusion
The study underscores the need for comprehensive care strategies that address both physical and psychological aspects of MS and NMOSD to enhance the quality of life for affected individuals.
